| GeneLibs

题目:: [Long- and short-term survivors after chemotherapy among patients with advanced or recurrent gastric cancer in our hospital].
作者:: Yamamoto(Manabu),Matsuyama(Ayumi),Kameyama(Toshifumi),Okamoto(Masahiro),Okazaki(Jin),Utsunomiya(Tohru),Tsutsui(Shinichi),Ishida(Teruyoshi)
状态:: 发布时间2008-04-14 , 更新时间 2008-04-14
期刊:: Gan To Kagaku Ryoho
摘要:: Since S-1 was approved in 1999, the response rate and the disease control rate of this chemotherapy for advanced or recurrent gastric cancer has been improved. Aa a result, we can plan for chemotherapy in patients with advanced or recurrent gastric cancer, because the median survival time (MST) with advanced or recurrent gastric cancer was over 20 months. We examined the characteristic findings of long- and short-term survivors in chemotherapy patients with advanced or recurrent gastric cancer. The prognosis for advanced gastric cancer is better than that for recurrent gastric cancer (p <0.02). In patients with only recurrent gastric cancer, the interval from surgery to recurrence is a significant prognostic factor. We thus show the results of chemotherapy for advanced or recurrent gastric cancer in our hospital and the characteristic findings in long- and short-term survivors for chemotherapy, and discuss effective planning of chemotherapy for each patient with advanced or recurrent gastric cancer.
语言:: jpn
DOI:

文献库文献相关信息